Inhalation Anesthesia Market: By Product Type (Sevoflurane, Desflurane, Isoflurane), By Application Type (Induction, Maintenance), and Geography

Inhalation Anesthesia Market size was valued at USD 1.43 billion in 2022 and is poised to grow at a CAGR of 4.94% from 2023-2029.  The rapid increase in the aging population with cancer, cardiovascular, spinal, orthopedic, respiratory, gastrointestinal, and other diseases and disorders is expected to drive the growth of the market. According to the WHO, cancer is one of the world's leading causes of morbidity and mortality, with nearly 18 million cases in 2019 alone, and is predicted to grow by around 70% over the next 20 years. Meanwhile, growing concern about the role of greenhouse gases such as sevoflurane, isoflurane, and desflurane in climate change could impede market growth. The Sevoflurane segment accounted for a share of sales of more than 70% in 2020 and the segment of induction was valued at about USD 250 million in 2019 and will expect similar trends in growth over the coming years. This study analyses the global inhalation anesthesia market dynamics in a detailed manner to identify current trends and drivers, growth opportunities, and potential challenges to the key stakeholders in the operating market.